Literature DB >> 15848006

Quantitation of active pharmaceutical ingredients and excipients in powder blends using designed multivariate calibration models by near-infrared spectroscopy.

Weiyong Li1, Gregory D Worosila.   

Abstract

This research note demonstrates the simultaneous quantitation of a pharmaceutical active ingredient and three excipients in a simulated powder blend containing acetaminophen, Prosolv and Crospovidone. An experimental design approach was used in generating a 5-level (%, w/w) calibration sample set that included 125 samples. The samples were prepared by weighing suitable amount of powders into separate 20-mL scintillation vials and were mixed manually. Partial least squares (PLS) regression was used in calibration model development. The models generated accurate results for quantitation of Crospovidone (at 5%, w/w) and magnesium stearate (at 0.5%, w/w). Further testing of the models demonstrated that the 2-level models were as effective as the 5-level ones, which reduced the calibration sample number to 50. The models had a small bias for quantitation of acetaminophen (at 30%, w/w) and Prosolv (at 64.5%, w/w) in the blend. The implication of the bias is discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15848006     DOI: 10.1016/j.ijpharm.2005.02.019

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  2 in total

1.  Applying terahertz technology for nondestructive detection of crack initiation in a film-coated layer on a swelling tablet.

Authors:  Wataru Momose; Hiroyuki Yoshino; Yoshifumi Katakawa; Kazunari Yamashita; Keiji Imai; Kazuhiro Sako; Eiji Kato; Akiyoshi Irisawa; Etsuo Yonemochi; Katsuhide Terada
Journal:  Results Pharma Sci       Date:  2012-04-13

2.  API Content and Blend Uniformity Using Quantum Cascade Laser Spectroscopy Coupled with Multivariate Analysis.

Authors:  Vladimir Villanueva-López; Leonardo C Pacheco-Londoño; Reynaldo Villarreal-González; John R Castro-Suarez; Andrés Román-Ospino; William Ortiz-Rivera; Nataly J Galán-Freyle; Samuel P Hernandez-Rivera
Journal:  Pharmaceutics       Date:  2021-06-29       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.